JOSÉ ÁNGEL
GARCÍA SÁENZ
Profesor asociado de Ciencias de la Salud
Instituto de Investigación Sanitaria La Fe
Valencia, EspañaInstituto de Investigación Sanitaria La Fe-ko ikertzaileekin lankidetzan egindako argitalpenak (9)
2021
-
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
Nature Communications, Vol. 12, Núm. 1
-
Erratum: Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature communications (2021) 12 1 (1078))
Nature communications
-
Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer-The Penelope-B Trial
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 39, Núm. 14, pp. 1518-1530
2020
-
Association between ABCB1 Genetic Variants and Persistent Chemotherapy-Induced Alopecia in Women with Breast Cancer
JAMA Dermatology, Vol. 156, Núm. 9, pp. 987-991
-
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Nature Genetics, Vol. 52, Núm. 1, pp. 56-73
2019
-
Survival impact of primary tumor resection in de novo metastatic breast cancer patients (GEICAM/El Alamo Registry)
Scientific Reports, Vol. 9, Núm. 1
2015
-
BRCA1 Alternative splicing landscape in breast tissue samples
BMC Cancer, Vol. 15, Núm. 1
2014
-
Assignment of tumor subtype by genomic testing and pathologic-based approximations: Implications on patient's management and therapy selection
Clinical and Translational Oncology, Vol. 16, Núm. 4, pp. 386-394
2013
-
Correlation between response to neoadjuvant chemotherapy and survival in locally advanced breast cancer patients
Annals of Oncology, Vol. 24, Núm. 3, pp. 655-661